PROM1 and colonic neoplasm: In order to make an efficient rectal delivery system for CRC, we first developed mucus-penetrating NPs of α-lactalbumin (α-La) PSs targeting a colon cancer stem cell antigen CD133 and co-loaded with miR-31i and Cur.